Endarterectomy or Carotid Artery Stenting? A Question That Still Generates Studies

Endarterectomy or Carotid Artery Stenting? A Question That Still Generates Studies

There have been several studies offering contradictory data on the relative effectiveness of carotid artery stenting and carotid artery endarterectomy for the prevention of stroke due to carotid artery stenosis.

 

The authors of this study performed a meta-analysis assessing the efficacy of these techniques, given recently published clinical trial data.

 

They selected randomized trials with at least 50 patients published as of April 30th, 2016, in order to compare both alternatives. Stenting had to include the use of distal-protection devices.

 

The study analyzed 6526 patients from 5 randomized trials with a mean follow-up of 5.3 years. The composite endpoint of peri-procedural death, infarction or stroke, plus non-peri-procedural ipsilateral stroke was similar between techniques (odds ratio [OR]: 1.22; 95% confidence interval [CI]: 0.94 to 1.59).

 

The risk of any peri-procedural stroke plus non-peri-procedural ipsilateral stroke was higher for patients who underwent stenting (OR: 1.50; 95% CI: 1.22 to 1.84). This higher risk of stroke was mostly attributed to peri-procedural minor stroke (OR: 2.43; 95% CI: 1.71 to 3.46).

 

Stenting was also associated with significantly lower risk of peri-procedural infarction (OR: 0.45; 95% CI: 0.27 to 0.75) and cranial nerve palsy.

 

Conclusion

Both carotid artery stenting and endarterectomy were associated with similar rates of a composite endpoint of peri-procedural death, infarction or stroke, plus non-peri-procedural ipsilateral stroke. The risk of long-term overall stroke was higher with stenting, mostly due to peri-procedural minor stroke, and lower rates of infarction and cranial nerve palsy than surgery.

 

Original title: Carotid Artery Stenting Versus Endarterectomy for Stroke Prevention. A Meta-Analysis of Clinical Trials.

Reference: Partha Sardar et al. J Am Coll Cardiol 2017;69:2266-75.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...